Login
Need to Register?   Forgot Password?
You need to upgrade your Flash Player to view this content.



What's New?
  • Latest data on PCSK9 inhibitors from ESC Congress 2014
    Slides on ODYSSEY LONG TERM, COMBOS II, & FH I & II of the novel PCSK9 inhibitor, alirocumab, from ESC14.
  • Case study: clinical application of the ACC/AHA cholesterol guidelines
    Join JoAnne Foody, MD, on an interactive journey toward primary prevention in a 48-year-old patient with LDL 150 and elevated ASCVD risk. Login required.
  • ACC/AHA lifestyle guidelines coverage
    Interactive summary recommendations & slides on the ACC/AHA lifestyle guidelines. Slides available for download in the slide library.
  • Your CVD guidelines resource
    Summary recommendations & slides on ACC/AHA cholesterol guidelines, AHA/ACC/TOS obesity guidelines, & more.
  • Dabigatran (Pradaxa) FDA Drug Safety Communication
    Lower risk for stroke and death, but higher risk for GI bleeding, seen with dabigatran vs warfarin among Medicare patients aged 65 or older. FDA has made no changes to Pradaxa labeling or recommendations for use. More here.
  • Not a member? What are you waiting for?
    Sign up now for exclusive access to downloadable slides and other content from CCMDweb.org. Registration is free and takes just a moment to complete.
  • CCMDweb.org: Professional Education
    for Cardiovascular Disease

    CCMDweb.org is a premier destination for professional education, clinically relevant information, and programs that augment knowledge and practice gaps in cardiovascular disease (CVD) with the goal of enhancing patient care. Since 1996, CCMD has partnered with preeminent thought leaders to educate US healthcare professionals on issues spanning the cardiovascular disease (CVD) spectrum—highlighting many cardiometabolic conditions that individually or collectively contribute to cardiovascular risk, including dyslipidemia, atherosclerosis, diabetes, stroke, inflammation, and obesity.

    A sample of the award-winning programs on CCMDweb.org:
    • Slide library with nearly 1,000 downloadable slides exploring cardiometabolic diseases
    • On-demand programs, including newsletters, case studies, and webcasts
    • Clinical guidelines resources
    • Expert commentaries on seminal research
    • Patient education handouts
    • And more!
    Registration is free and unlocks premium content offerings and incentives. Sign up here.

    CCMDweb.org is the official website of The Committee on Cardiovascular and Metabolic Diseases™ (CCMD™), a multi-component independent educational initiative offering programs and resources focused on the management of cardiovascular and metabolic diseases as a means to prevent or reduce global cardiovascular risk. Click here for more information about CCMD.
    In the News
    Diabetic men with low testosterone run higher risk of developing atherosclerosis
    Oct 20, 2014 -- Men who have low testosterone and Type 2 diabetes face a greater risk of developing atherosclerosis - a condition where plaque builds up in the arteries - than men who have diabetes and normal...

    New research may prove relevant to treating disorders characterized by misfolded proteins - PD, CVD, and cystic fibrosis
    Oct 20, 2014 -- Patients with Parkinson's disease, cardiovascular disease, and cystic fibrosis may have something in common: cells in their disease-affected tissues may produce misfolded proteins that are...

    Copyright 2014 Medical News Today